Cargando…
Hypoxic respiratory failure due to hyperammonemic encephalopathy induced by concurrent use of valproic acid and topiramate, a case report and review of the literature
Valproic acid (VPA) is widely used for the treatment of epilepsy, migraine, and a variety of psychiatric symptoms, including bipolar disorder, borderline personality disorder, and alcohol withdrawal. Valproate is associated with severe idiosyncratic adverse effects, the most notable being valproate-...
Autores principales: | Raru, Yonas, Zeid, Fuad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986170/ https://www.ncbi.nlm.nih.gov/pubmed/29872630 http://dx.doi.org/10.1016/j.rmcr.2018.05.026 |
Ejemplares similares
-
Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction
por: Twilla, Jennifer D., et al.
Publicado: (2014) -
Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam
por: Roh, Sook Young, et al.
Publicado: (2014) -
A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy
por: Iqbal, Kinza, et al.
Publicado: (2021) -
Hyperammonemic Encephalopathy: valproic acid-induced adverse reaction
por: Gómez, E., et al.
Publicado: (2023) -
Valproic acid-induced hyperammonemic encephalopathy: a clinical case
por: Felizardo, M., et al.
Publicado: (2022)